PharmaDax Inc. announced earnings results for the full year ended December 31, 2018. For the full year, the company announced sales was TWD 35.882 million compared to TWD 56.209 million a year ago. Operating loss was TWD 441.853 million compared to TWD 382.527 million a year ago. Net loss was TWD 374.323 million compared to TWD 386.905 million a year ago. Basic loss per share was TWD 6.77 compared to TWD 7.04 a year ago.